INTRODUCTION
============

Cytokinesis, the final stage in cell division, results in the physical separation of two daughter cells. This event is accomplished in many eukaryotic cells by an actin- and myosin-based contractile ring (CR) that forms and constricts between the two segregated genomes. In *Schizosaccharomyces pombe*, CR assembly depends on a single formin, Cdc12, which nucleates, elongates, and bundles F-actin of the CR ([@B30]; [@B7]; [@B21]; [@B22]; [@B5]).

Cdc12 targeting to the CR at mitotic onset depends on two redundant genetic modules ([@B42]; [@B23]). The first module consists of IQGAP Rng2 and non-muscle myosin II (Myo2, Cdc4, and Rlc1), while the second module consists of the F-BAR scaffold Cdc15 ([@B23]). Although the molecular mechanism by which the first module recruits Cdc12 is still unknown, Cdc15's F-BAR domain interacts directly with Cdc12 and recruits it to the CR. We identified the Cdc15-binding motif within the Cdc12 N-terminus (residues 24--36) and also found that a *cdc12-P31A* mutant, in which the Cdc15-binding motif on Cdc12 is disrupted, had reduced Cdc12 CR localization, delayed medial F-actin accumulation and CR formation, and decreased viability upon CR perturbation ([@B44]). Thus, the Cdc12--Cdc15 interaction is an important contributor to Cdc12 localization and CR formation.

Cdc15 is a member of the F-BAR family of proteins, which oligomerize and bind membranes through their F-BAR domains ([@B40]; [@B25]; [@B24]) and link the membrane to other proteins ([@B33]; [@B4]; [@B32]). Cdc15 activity is under strong cell cycle--dependent phosphoregulation: Cdc15 is hyperphosphorylated during interphase, but hypophosphorylated in mitosis ([@B12]). Cdc15 hyperphosphorylation inhibits its membrane binding, oligomerization, and binding to protein partners. Cdc15 dephosphorylation, in contrast, induces an open conformation that supports these activities ([@B34]; [@B25]). Cdc12 and Cdc15 associate when Cdc15 is hypophosphorylated; interestingly, *cdc15* alleles with phospho-abolishing mutations precociously recruit Cdc12 and other interacting proteins to the cell middle ([@B34]). Thus, while Cdc15 phosphoregulation controls its interaction with Cdc12 and other binding partners, whether or not Cdc12 is also regulated to control its interaction with Cdc15 was unknown.

Like Cdc15, Cdc12 is phosphorylated in a cell cycle--dependent manner; but, unlike Cdc15, its hyperphosphorylation occurs during mitosis, not interphase ([@B5]). Sid2, the terminal kinase in the septation initiation network (SIN), phosphorylates Cdc12 on four residues to regulate a C-terminal oligomerization domain ([@B5]). When all four Sid2 phospho-sites are mutated to phospho-abolishing residues, Cdc12 is still phosphorylated in vivo ([@B5]), suggesting that other kinases must also phosphorylate Cdc12.

Cdk1 (cyclin-dependent kinase) is a master controller of the cell cycle. Though Cdk1 is required for mitotic commitment, cytokinesis is not initiated until later in mitosis when Cdk1 activity is low ([@B17]; [@B43]; [@B16]; [@B29]; [@B31]; [@B45]; [@B10]; [@B2]). As low Cdk1 activity is a hallmark of mitotic exit, Cdk1 is commonly regarded as a cytokinetic inhibitor (reviewed in [@B45]; [@B3]). A recent study identified threonine 95 on Cdc12 as a Cdk1 target site ([@B39]), yet the role of this phosphorylation was unknown.

Here we show that Cdk1 phosphorylates Cdc12 on six N-terminal residues, inhibiting its interaction with the Cdc15 F-BAR domain. Cells producing only Cdc12-6D, which has phospho-mimetic residues at the six Cdk1 sites, display phenotypes similar to those of *cdc12-P31A* cells, which lack the Cdc15-binding motif on Cdc12; both have reduced Cdc12 accumulation at the cell division site and delayed CR formation. These results underscore the multitiered regulation of formin activity during cytokinesis and are consistent with a role for Cdk1 in inhibiting cytokinesis until chromosome segregation is complete.

RESULTS and discussion
======================

Cdc12 is a Cdk1 substrate
-------------------------

Loss of Sid2 activity only partially eliminated Cdc12 phosphorylation ([@B5]), indicating that other kinases also phosphorylate Cdc12. Peak Cdc12 phosphorylation correlates temporally with high Cdk1 activity, and threonine 95 on Cdc12 was identified in a large-scale phosphoproteomics screen designed to identify Cdk1 substrates ([@B39]). Another phosphoproteomics screen identified a host of mitotic Cdc12 phosphopeptides ([@B20]). Thus, we investigated whether Cdk1 is involved in Cdc12 phosphoregulation. The Cdc12 N-terminus was robustly phosphorylated by Cdk1 in vitro ([Figure 1, A and B](#F1){ref-type="fig"}). In accord with the known Cdk1 consensus site, all targeted residues were within S/T-P motifs (Supplemental Figure S1). Individual mutation of each Cdk1 consensus site identified residues T20, T22, S64, T151, and S463 and confirmed T95 as major Cdk1-targeted residues (Supplemental Figure S1, B and C). When all six phosphosites were mutated to alanine, Cdk1-mediated Cdc12 phosphorylation was abolished ([Figure 1, A and B](#F1){ref-type="fig"}). We constructed an endogenously expressed *cdc12* allele in which all six phosphorylated residues were mutated to alanine (*cdc12-6A*). When immunoprecipitated from mitotically arrested cells, we detected a reduced mobility shift for Cdc12-6A-HA~3~ in comparison to Cdc12-HA~3~ ([Figure 1C](#F1){ref-type="fig"}), indicating that these residues are in vivo phosphosites. Consistent with Cdk1 phosphorylating Cdc12 in vivo, Cdc12-HA~3~ showed increased gel mobility when incubated with recombinant MBP-Clp1 in comparison with Cdc12-HA~3~ not incubated with protein or incubated with an inactive form of Clp1 ([Figure 1D](#F1){ref-type="fig"}). Clp1 is a phosphatase that dephosphorylates Cdk1 phosphosites ([@B15]; [@B38]; [@B9]; [@B27]; [@B8]). Taking these results together, we conclude that Cdk1 phosphorylates Cdc12 during mitosis.

![Cdc12 is a Cdk1 substrate. (A) In vitro kinase assay using Cdk1--Cdc13 purified from insect cells and bacterially produced MBP, MBP-Cdc12(1--765), and MBP-Cdc12(1--765-6A) fragments. The gel was stained with Coomassie blue (CB) and proteins labeled by γ--P^32^ were detected by autoradiography. (B) Schematic of Cdc12 with formin homology (FH) domains 1 and 2, armadillo repeats (ARM), oligomerization domain (C'), and Cdk1-targeted residues labeled. The Cdc15-binding motif (residues 24--36) is indicated by the black bar. T95, identified by [@B39], is labeled with an asterisk. (C, D) Denatured cell lysates were prepared from the indicated mitotically arrested *mts3-1* strains. Anti-HA immunoprecipitates of the samples were (C) subjected to lambda phosphatase treatment or buffer control or (D) incubated with MBP-Clp1, MBP-Clp1-C286S, or buffer control. Samples were resolved by SDS--PAGE and immunoblotted. CDK served as loading control. Brackets span phosphorylated species and asterisks mark hypophosphorylated species of Cdc12. (E) In vitro binding assay of bead-bound recombinant MBP, MBP-Cdc12(1--765), or MBP-Cdc12(1--765-6A) with recombinant Cdc15 F-BAR(19--312) incubated with either kinase active (KA) or kinase dead (KD) Cdk1--Cdc13. Uncropped images are in Supplemental Figure S2B. (F) In vitro binding assay of bead-bound recombinant MBP, MBP-Cdc12(1--765), MBP-Cdc12(1--765-6A), or MBP-Cdc12(1--765-6D) with recombinant Cdc15 F-BAR(19--312). Uncropped images are in Supplemental Figure S2C. (E, F) Samples were washed, resolved by SDS--PAGE, and stained with CB.](mbc-29-713-g001){#F1}

Cdk1 phosphorylation of Cdc12 inhibits the Cdc12--Cdc15 interaction
-------------------------------------------------------------------

Because Cdk1 phosphorylation sites on Cdc12 are near the Cdc15-binding motif ([Figure 1B](#F1){ref-type="fig"}; [@B44]), we investigated whether Cdc12 phosphorylation affects its binding to Cdc15 F-BAR. In vitro, MBP-Cdc12(1--765) bound Cdc15 F-BAR ([Figure 1E](#F1){ref-type="fig"}; [@B6]; [@B44]), which runs as a double band due to incomplete His~6~-tag cleavage (Supplemental Figure S2A). However, incubation of MBP-Cdc12(1--765) with Cdk1 prevented Cdc15 F-BAR binding ([Figure 1E](#F1){ref-type="fig"}; Supplemental Figure S2B), suggesting that phosphorylation at the Cdk1-targeted residues blocks this interaction. Consistent with this interpretation, Cdk1 no longer affected the interaction when all six Cdk1 phosphosites on Cdc12 were mutated to alanine ([Figure 1E](#F1){ref-type="fig"}; Supplemental Figure S2B). Further, a Cdc12 fragment with all six Cdk1 sites mutated to phosphomimetic aspartate residues did not bind Cdc15 F-BAR in vitro ([Figure 1F](#F1){ref-type="fig"}; Supplemental Figure S2C). These results indicate that Cdk1 phosphorylates Cdc12 on six residues to preclude Cdc15 binding.

Cells with constitutive inhibition of the Cdc12--Cdc15 interaction are prone to cytokinesis failure
---------------------------------------------------------------------------------------------------

To determine the functional consequence of abolishing or constitutively mimicking Cdc12 N-terminal phosphorylation by Cdk1 in cells, we examined *cdc12* alleles in which Cdc12's six N-terminal Cdk1 phosphorylation sites were mutated to either alanines (*cdc12-6A*) or aspartates (*cdc12-6D*). On the basis of the in vitro results, we expected that the *cdc12-6D* allele might cause phenotypes similar to the *cdc12-P31A* allele, which disrupted Cdc12's association with Cdc15 and was synthetically lethal with *myo2-E1*, *rng2-D5*, and *mid1∆* ([@B44])*.* As expected, *cdc12-6D* was synthetically lethal with *myo2-E1* ([Figure 2A](#F2){ref-type="fig"}) and synthetically sick with *rng2-D5* and *mid1∆* ([Figure 2B](#F2){ref-type="fig"}). DAPI staining of *wildtype, cdc12-6D, rng2-D5*, and *cdc12-6D rng2-D5* revealed that the double mutant had a higher percentage of multiple nuclei indicative of cytokinesis failure than the wild type and single mutants ([Figure 2C](#F2){ref-type="fig"}). Contrary to expectation, *cdc12-6A* also displayed negative genetic interactions with *myo2-E1*, *rng2-D5*, and *mid1∆* ([Figure 2B](#F2){ref-type="fig"}), although these were much milder than those of *cdc12-6D*. It could be that 1) improper temporal regulation of the Cdc12--Cdc15 interaction is detrimental to cytokinesis, 2) Cdk1-mediated phosphorylation at these sites must be dynamic to support correct Cdc12 function during mitosis, 3) phosphorylation affects another unknown Cdc12 interaction, or 4) the 6A mutants negatively affect the overall structure and function of full-length Cdc12.

![Genetic interactions of *cdc12-6A* and *cdc12-6D*. (A) Tetrads from *cdc12-6D* crossed to *myo2-E1* shown with a schematic of relevant genotypes. (B) Cells of the indicated genotypes were spotted on YE media in 10-fold serial dilution, and plates were imaged after incubation for 3 d at the indicated temperatures. (C) The indicated strains were grown at 25°C and shifted to 36°C for 4 h before fixing and staining. Representative images are shown on the left and the percentage of cells with more than two nuclei is quantified on the right. *n* ≥ 500 for each strain. Bar, 5 μm.](mbc-29-713-g002){#F2}

Cdk1-dependent regulation of the Cdc12--Cdc15 interaction is important for Cdc12 recruitment
--------------------------------------------------------------------------------------------

Cdc12--Cdc15 binding is important in recruiting Cdc12 to the CR ([@B23]; [@B44]). To test whether Cdk1 phosphorylation of Cdc12 influences Cdc12's CR localization, we tagged wild-type and mutant alleles with a single copy of mNeonGreen (mNG) ([@B36]). As expected, Cdc12-6D-mNG had substantially decreased CR localization, even compared with Cdc12-P31A-mNG ([Figure 3, A and B](#F3){ref-type="fig"}), and Cdc12-6A-mNG CR localization was intermediate between wild type and Cdc12-P31A-mNG ([Figure 3, A and B](#F3){ref-type="fig"}). However, there was no difference among strains in total Cdc12 protein levels in mitotic cells ([Figure 3, A and B](#F3){ref-type="fig"}). These data are consistent with Cdk1 phosphorylation of Cdc12 modulating Cdc12 targeting to the CR in vivo.

![Cdk1 phosphorylation of Cdc12 inhibits its CR localization. (A) Live-cell imaging of endogenously tagged *cdc12-mNG*, *cdc12-P31A-mNG*, *cdc12-6D-mNG*, and *cdc12-6A-mNG*. Arrows indicate CR localization of Cdc12. (B) Quantification of Cdc12 fluorescence intensity in the CR (left) and whole cell (right) from images of the indicated genotypes. A.U. = arbitrary units. (In right graph, *cdc12* vs. *cdc12-P31A p* = 0.13; wt vs. *cdc12-6D p* = 0.92; and wt vs. *cdc12-6A p* = 0.33.) Measurements from three biological replicates. In left graph: **\*\****p* ≤ 0.01 **and \*\*\*\****p* ≤ 0.0001, one-way ANOVA. Error bars represent SEM. (C) Cdc12-mNG localization in cells overexpressing *cdc15* from the *nmt81* promoter for 20 h at 32°C. (D) Quantification of the images from C. Bars in A and C, 5 μm.](mbc-29-713-g003){#F3}

Cdc15 also influences Cdc12 localization in abnormal cell cycle situations ([@B6]; [@B34]). For example, *cdc15* overexpression results in the formation of large puncta of Cdc12 ([@B6]). As previously reported, the P31A mutation in *cdc12* prevents puncta formation because it disrupts the Cdc15--Cdc12 interaction ([Figure 3, C and D](#F3){ref-type="fig"}; [@B44]). Consistent with Cdk1 phosphorylation inhibiting Cdc12 medial recruitment, Cdc12-6D-mNG formed puncta in only 4% of *cdc15*-overexpressing cells. *cdc12-6A-mNG* cells displayed puncta more commonly, but less than *cdc12-mNG* cells ([Figure 3, C and D](#F3){ref-type="fig"}). All strains overexpressed Cdc15 to approximately the same level (Supplemental Figure S2D). Thus, under both normal and abnormal conditions, Cdk1-dependent phosphorylation modulates the medial recruitment of Cdc12 by affecting its interaction with Cdc15.

Cdk1-dependent regulation of the Cdc12--Cdc15 interaction is important in the initial formation of F-actin
----------------------------------------------------------------------------------------------------------

Previous findings showed that reduced Cdc12 recruitment to the division site results in less F-actin during early mitosis, but not anaphase B ([@B44]). We thus visualized F-actin with LifeAct-mCherry and compared the amount of F-actin in the CR of *cdc12* phosphomutant cells during early mitosis and anaphase B. In early mitosis, there was 20% less F-actin in the CR of *cdc12-P31A* cells compared with wild type, and 16% less F-actin in the CR of *cdc12-6D* cells ([Figure 4, A and B](#F4){ref-type="fig"}). However, there was no statistically significant difference of *cdc12-6A* cells from wild type (*p* = 0.29) during early mitosis ([Figure 4, A and B](#F4){ref-type="fig"}). In addition, there was no statistically significant difference in the amount of F-actin in the CR between any of the strains during anaphase B ([Figure 4, A and B](#F4){ref-type="fig"}). Thus, Cdc12-6D, similarly to Cdc12-P31A, initially produces less F-actin in the forming CR, but with time is able to reestablish typical F-actin levels.

![Mimicking constitutive Cdk1 phosphorylation on Cdc12 reduces F-actin in the CR. (A) Live-cell imaging of *cdc12^+^*, *cdc12-P31A*, *cdc12-6D*, *and cdc12-6A* cells expressing LifeAct-mCherry Sid4-GFP. (B) Quantification of fluorescence intensity of LifeAct-mCherry CRs in the indicated genotypes and cell cycle stage (*cdc12^+^* vs. *cdc12-6A* early mitosis *p* = 0.29; *cdc12^+^* vs. *cdc12-P31A* anaphase B *p* = 0.67; *cdc12^+^* vs. *cdc12-6A* anaphase B *p* = 0.56; *cdc12^+^* vs. *cdc12-6D* anaphase B *p* = 0.76). (C, E) Live-cell imaging of *cdc12^+^*, *cdc12-P31A*, *cdc12-6D*, and *cdc12-6A* cells expressing endogenously tagged mCherry-Cdc15 Sid4-RFP (C) or Ain1-GFP Sid4-GFP (E). (D, F) Quantification of fluorescence intensity of mCherry-Cdc15 (D) and Ain1-GFP (F) CRs in the indicated strain and cell cycle stage. (D) *cdc12^+^* vs. *cdc12-P31A* anaphase B *p* = 0.63; *cdc12^+^* vs. *cdc12-6A* anaphase B *p* = 0.37. (F) *cdc12^+^* vs. *cdc12-P31A* early mitosis *p* = 0.95; *cdc12^+^* vs. *cdc12-6A* early mitosis *p* = 0.97; *cdc12^+^* vs. *cdc12-6D* early mitosis *p* = 0.88; *cdc12^+^* vs. *cdc12-P31A* anaphase B *p* = 0.92; *cdc12^+^* vs. *cdc12-6A* anaphase B *p* = 0.63; *cdc12^+^* vs. *cdc12-6D* anaphase B *p* = 0.84. Measurements in the graphs from B, D, and F represent three biological replicates. Bars, 5 μm. **\****p* ≤ 0.05, **\*\****p* ≤ 0.01, and **\*\*\*\****p* ≤ 0.0001, one-way ANOVA. Error bars represent SEM. A.U. in panels B, D, and F = arbitrary units.](mbc-29-713-g004){#F4}

We expected that proteins targeted to the CR independently of Cdc12 and F-actin, such as Cdc15 ([@B47]), would not be affected in *cdc12* phosphomutants. Indeed, mCherry-Cdc15 did not have altered protein levels in CRs of mutant cells compared to those of wild type at any mitotic stage ([Figure 4, C and D](#F4){ref-type="fig"}). In contrast, proteins that localize to the CR in an F-actin--­dependent manner might exhibit decreased CR abundance in early mitotic *cdc12* phosphomutants. Indeed, during early mitosis, there was a 30% decrease in Ain1-GFP (alpha-actinin, [@B46]) abundance in the CRs of *cdc12-P31A* cells and a 24% decrease in *cdc12-6D* cells ([Figure 4, E and F](#F4){ref-type="fig"}). A significant decrease was not observed for Ain1-GFP in early mitotic *cdc12-6A* cells ([Figure 4, E and F](#F4){ref-type="fig"}). Like F-actin, Ain1-GFP recovered to wild-type levels during anaphase B in *cdc12-P31A* cells, but remained slightly reduced in *cdc12-6D* cells ([Figure 4, E and F](#F4){ref-type="fig"}).

Cdk1-dependent phosphorylation of Cdc12 is important during CR formation
------------------------------------------------------------------------

Because our results indicated that phosphomodulation of the Cdc15--Cdc12 interaction adversely affects CR assembly, we used time-lapse microscopy to examine cytokinesis in its entirety. Rlc1-GFP and Sid4-GFP served as markers for the CR and mitotic progression, respectively. As reported previously, CR formation (the time from SPB separation to the appearance of a CR) in *cdc12*-*P31A* cells was delayed by ∼4 min (29% slower than for wild type). A similar delay in CR formation was seen for *cdc12-6D* cells (35% slower; [Figure 5, A and B](#F5){ref-type="fig"}), consistent with the reduction in F-actin. *cdc12-6D* also displayed a shorter maturation period (the time from CR formation to constriction onset) and slightly longer CR constriction ([Figure 5, A and B](#F5){ref-type="fig"}). Consistent with other phenotypes of the *cdc12-6A* allele manifesting as an intermediate between wild type and *cdc12-6D*, it had a relatively slight delay in CR formation (21% slower; [Figure 5, A and B](#F5){ref-type="fig"}).

![Mimicking constitutive Cdc12 phosphorylation delays CR formation. (A) Live-cell imaging of *cdc12^+^*, *cdc12-P31A*, *cdc12-6D*, or *cdc12-6A* cells expressing Rlc1-GFP Sid4-GFP. Images were acquired every 2 min. Bar, 5 μm. The time point indicated in magenta is the first in which a complete ring is detected. (B) Quantification of cytokinesis event timing for each strain. Measurements are from at least three biological replicates. **\****p* ≤ 0.05, **\*\*\****p* ≤ 0.001, and **\*\*\*\****p* ≤ 0.0001, one-way ANOVA. Error bars represent SEM.](mbc-29-713-g005){#F5}

In summary, this study confirms that the cytokinetic formin Cdc12 is a Cdk1 substrate. In vitro, Cdk1 phosphorylation of six N-terminal residues on Cdc12 inhibits its interaction with the F-BAR domain of Cdc15. Cells expressing a *cdc12* phospho-mimetic 6D mutant showed phenotypes similar to those of cells in which the Cdc15-binding motif on Cdc12 had been mutated; both exhibit reduced Cdc12 CR localization and delayed F-actin accumulation in the CR, leading to defects in CR formation. Thus, the in vitro inhibition of Cdc12--Cdc15 binding by Cdk1 is consistent with what happens in vivo. The phenotypes of the Cdc12-6A mutant, however, do not lend themselves to such a straightforward interpretation. Though alanine substitutions of the Cdk1 sites in the Cdc12 N-terminus do not impact Cdc15 F-BAR interaction in vitro, they do modify protein function in vivo. One possible explanation is that the 6 N-terminal alanine substitutions impact an unknown Cdc12 binding partner or regulator. Another binding partner clearly exists, based on genetic evidence ([@B23]) and the fact that Cdc12 localizes to the CR in the absence of Cdc15 F-BAR binding and F-actin ([@B44]). Another potential explanation for the slight loss of function of Cdc12-6A is a need for dynamic Cdc12--Cdc15 interactions during CR assembly. FRAP experiments indicate that Cdc12 turns over rapidly in the CR ([@B48]); altering Cdc12 interactions may affect its dynamics and be detrimental to CR function. Last, the 6A mutations might simply disturb the structure of Cdc12. In addition to phosphorylating Cdc12's N-terminus, Cdk1 phosphorylates at least one additional site in Cdc12's C-terminus in vivo (Ser 1798) ([@B39]). It will be interesting to define a function for this phosphorylation site and to determine whether it cooperates with SIN-dependent phosphorylation to control the nearby Cdc12 multimerization domain ([@B5]).

At least some Cdk1 phosphosites on Cdc12 are dephosphorylated by Clp1, a member of the Cdc14 phosphatase family, thereby allowing maximal Cdc12 accumulation at the CR. Indeed, Cdc12 localizes to the CR, concomitant with Clp1 ([@B9]). Bni1 and Bnr1, two redundant cytokinetic formins in budding yeast, are direct Cdc14 targets whose localization to the cell division site is dependent on Cdc14-mediated dephosphorylation ([@B2]). Therefore, formin-dependent modification by Cdk1/Cdc14 may be a conserved mechanism by which formin subcellular localization is controlled during cytokinesis.

Multiple CR components may be phosphorylated and regulated by Cdk1. *Saccharomyces cerevisiae* Iqg1 (Rng2 in *S. pombe* and IQGAPs in humans) was identified as a direct Cdk1 target ([@B18]; [@B28]; [@B26]). Abolishing Cdk1-mediated phosphorylation of Iqg1 results in precocious CR formation prior to anaphase. Thus, similarly to our study, these findings suggest that Cdk1 phosphorylation of CR components counteracts early CR formation. Interestingly, Rng2 binds Clp1, indicating that it is also a Cdk1 target ([@B8]). Thus, it will be interesting to determine whether Rng2 phosphorylation similarly inhibits its CR localization, and how such regulation, or that of other CR components, is coordinated with Cdk1-mediated phosphoinhibition of formin localization to fine-tune assembly of the cell division apparatus.

MATERIAL AND METHODS
====================

Yeast methods
-------------

*S. pombe* strains (Supplemental Table S1) were grown in yeast extract (YE). To make endogenous *cdc12-6A* and *cdc12-6D* alleles, a pSK vector (pBluescript backbone) was constructed that contained, in the following order, 5′ *cdc12* flank including its promoter, full-length *cdc12^+^*, kan^R^ cassette, and 3′ *cdc12* flank (pKG 5431) ([@B5]). The *cdc12-6A* and *cdc12-6D* mutations were created by site-directed mutagenesis of pKG 5431 by PCR and confirmed with sequencing. The mutant constructs were then released from the vector by digestion with *Xba*I and *Sac*I and transformed into wild-type *S. pombe* cells using a lithium acetate method ([@B19]). G418-resistant cells were selected and the *cdc12* locus was sequenced to identify transformants containing the desired and correct mutations. *cdc12^+^*, *cdc12-6A*, and *cdc12-6D* were tagged endogenously at the 3′ end with HA~3~:kan^R^ or HA~3~:hyg^R^ using pFA6 cassettes as previously described ([@B41]; [@B1]).

*cdc12^+^*, *cdc12-6A*, and *cdc12-6D* endogenously tagged mNG alleles were made using a pSK vector that contained a 5′ *cdc12* flank including its promoter, full-length *cdc12^+^*, and sequences encoding mNG, kan^R^ cassette, and 3′ *cdc12* flank (pKG 7922). mNG is a green fluorescent protein derived from the lancelet *Branchiostoma lanceolatum* that was chosen for imaging experiments because of its superior brightness ([@B36]) (Allele Biotechnology). The constructs were then released from the vector by digestion with *Xba*I and *Sac*I and transformed into wild-type *S. pombe* cells using a lithium acetate method ([@B19]). G418-resistant cells were selected and the *cdc12* locus was sequenced to identify transformants containing the desired and correct mutations and tag.

For growth assays, cells were grown to log phase at 25°C in YE, 10 million cells were resuspended in 1 ml of YE, and 10-fold serial dilutions were made. Then 2.5 μl of each dilution was spotted on YE plates and the plates were incubated at the indicated temperatures.

Protein expression and purification
-----------------------------------

Cdc12(1--765), Clp1, and Clp1-C286S were cloned into pMAL-c2 for expression as an MBP fusion ([@B6]; [@B9]; [@B8]). Cdc15 F-BAR (19--312) was cloned into pET15b for expression as a His~6~ fusion ([@B44]). Proteins were induced in *Escherichia coli* Rosetta2(DE3)pLysS cells with 0.4 mM IPTG overnight at 18°C. Proteins were purified on amylose beads (New England Biolabs) or cOmplete His-Tag resin (Roche) according to the manufacturer's protocols. Cdc15(19--312)'s His~6~ tag was removed with thrombin protease and the protein was further purified on a HiTrap Q SP anion exchange column (GE Healthcare) and concentrated.

Protein methods
---------------

Cell pellets were snap-frozen in dry ice--ethanol baths. Lysates were prepared using a Fastprep cell homogenizer (MP Biomedicals). Immunoprecipitations were performed as previously described ([@B14]) in NP-40 buffer containing SDS for denatured lysates. Protein samples were resolved by SDS--PAGE and transferred to polyvinylidene fluoride (PVDF) membrane (Immobilon P; EMD Millipore). Anti-HA (12CA5), anti-Cdc2 (PSTAIRE; Sigma), or anti-Cdc15 ([@B33]) was used in immunoprecipitations and/or as a primary antibody in immuno­blotting. Secondary antibodies were conjugated to IRDye800 or IRDye680 (LI-COR Biosciences). Blotted proteins were detected via an Odyssey Classic (LI-COR Biosciences). For gel shifts, denatured lysates were treated with λ-phosphatase (New England Biolabs) in 25 mM HEPES-NaOH (pH 7.4), 150 mM NaCl, and 1 mM MnCl~2~ and incubated for 30 min at 30°C with shaking. The Clp1 phosphatase assay was performed as previously described ([@B8]) with minor modifications. Briefly, Cdc12-HA~3~ was immunoprecipitated from 180 ODs of cells (6 30 OD pellets per sample) from a 3-h *mts3-1* arrest using 4 µg of 12CA5 antibody and 20 µl of PureProteome protein G magnetic beads (Millipore). Beads were washed twice with 1 ml NP-40 buffer and once with 1 ml of Clp1 phosphatase buffer (50 mM imidazole, pH 6.9, 1 mM EDTA, and 1 mM dithiothreitol \[DTT\]), divided into three equal parts. The first was treated with buffer alone, the second with 200 ng of MBP-Clp1, and the third with 200 ng of MBP-Clp1-C286S in 20-μl reactions composed of 1 × Clp1 phosphatase buffer. The samples were then incubated for 30 min at 30°C with shaking before the reaction was quenched with 5 μl of 5x SDS sample buffer. Where indicated, samples were resolved by SDS--PAGE in the presence of 5 μM PhosTag acrylamide per the manufacturer's protocol (Wako Chemical USA).

Kinase reactions were performed in protein kinase buffer (10 mM Tris, pH 7.4, 10 mM MgCl~2~, and 1 mM DTT) with 10 μM cold ATP, 3 μCi of \[^32^P\]ATP, and 100 ng of kinase-active or kinase-dead insect cell--produced Cdk1-Cdc13 in 20 μl reactions that were incubated at 30°C for 30 min with shaking. MBP was used as a control substrate for Cdk1-Cdc13. Reactions were quenched by the addition of 5 μl of 5x SDS sample buffer. Proteins were separated by SDS--PAGE and transferred to PVDF membrane, and phosphorylated proteins were visualized by autoradiography. Kinase assays, phosphoamino acid analysis, and tryptic peptide mapping were performed as described in ([@B37];  [@B13]) and references therein. In vitro phosphorylation of recombinant proteins used in in vitro binding assays was performed via identical kinase assays, except that radioactive \[γ^32^P\]ATP was eliminated, and the final concentration of unlabeled ATP in reactions was increased to 2 mM.

In vitro binding
----------------

Recombinant proteins conjugated to amylose beads were incubated with recombinant Cdc15 F-BAR for 1 h at 4°C in 1 ml binding buffer (50 mM Tris-HCl, pH 7.0, 250 mM NaCl, 2 mM EDTA, 0.1% NP-40). Following extensive washing in binding buffer, samples were resolved by SDS--PAGE for CB staining.

Microscopy
----------

Live-cell images of *S. pombe* cells were acquired using either a personal DeltaVision microscope system (Applied Precision) that includes an Olympus IX71 microscope, 60 × NA 1.42 PlanApo, fixed- and live-cell filter wheels, a Photometrics CoolSnap HQ2 camera, and softWoRx imaging software or a spinning disk confocal microscope (Ultraview LCI; PerkinElmer, Waltham, MA) equipped with a 63 × 1.46 NA PlanApochromat oil immersion objective (Zeiss), an EM-CCD ImagEM X2 camera (Hamamatsu) and µManager software ([@B11]).

Images were acquired at 25--29°C and cells were imaged in YE media. Images were acquired using 0.5 µm *z* spacing. Representative images in [Figure 3](#F3){ref-type="fig"} were deconvolved with 10 iterations and are maximum-intensity projections. Representative images in [Figure 4](#F4){ref-type="fig"} are maximum-intensity projections. Images used for quantification in [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"} were not deconvolved and were sum projected.

Time-lapse imaging was performed on cells in log phase using an ONIX microfluidics perfusion system (CellASIC). Cells were loaded into Y04C plates for 5 s at 8 psi, and YE liquid media was flowed into the chamber at 5 psi throughout imaging. For [Figure 5](#F5){ref-type="fig"}, CR formation is the time from SPB separation to CR formation, maturation is the time from CR formation to the start of CR constriction, and CR constriction is the time from the first frame of CR constriction until the frame where the CR is completely constricted and has disassembled.

Intensity measurements were made with ImageJ software (<http://rsweb.nih.gov/ij/>; [@B35]). For all intensity measurements, the background was subtracted by creating a region of interest (ROI) in the same image where there were no cells. The raw intensity of the background was divided by the area of the background, which was multiplied by the area of the ROI. This number was subtracted from the raw integrated intensity of that ROI. For CR intensity quantification, an ROI was drawn around the CR and measured for raw integrated density, and for whole cell intensity quantification an ROI was drawn around the entire cell. To compare populations of cells for all genotypes, cells were imaged on the same day with the same microscope parameters.

For DAPI and methyl blue staining, cells were grown to log phase at 25°C, shifted to 36°C, and then fixed in 70% ethanol for at least 30 min.

All statistical analyses of variance (ANOVAs) used Tukey's post hoc analysis.
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Cdk1

:   cyclin-dependent kinase 1

CR

:   contractile ring

F-actin

:   filamentous actin

MBP

:   maltose-binding protein

mNG

:   mNeonGreen.

[^1]: ^†^Present address: Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803.
